OPTISTEM

Optimization of Stem cell Therapy for degenerative Epithelial and Muscle Diseases

OptiStem is an EU-funded research project that brings together stem cell biologists and clinical experts from across Europe investigating stem cells in skeletal muscle and epithelia. OptiStem combines basic research about stem cells with pre-clinical work and clinical trials. All these areas of research are vital to understand how to use stem cells in the fight against disease. It will be investigated how stem cells could be used to treat degenerative diseases that damage skeletal muscle or epithelia such as skin or the surface of the eye.

Partner

France

Institut nationale de la santé et de la recherche médicale (INSERM)

Pasteur Institute

Germany

Helmholtz Centre for Infection Research

Miltenyi Biotec GmBH

Italy

E. Medea Scientific Institute

FIRC Institute of Molecular Oncology Foundation

MolMed S.p.A.

San Rafaelle del Monte Tabor Foundation

University of Milan

University of Modena

Spain

University Pompeu Fabra

Switzerland

Centre Hospitalier Universitaire Vaudois CHUV

Ecole Polytechnique Fédéral de Lausanne

UK

Cancer Research UK

Dando & Colucci LLC

King’s College London

University of Edinburgh

University of Oxford

 

Sprecher

Regina Becker

Koordinator

University of Milan (IT)

Homepage

http://www.optistem.org/

Geldgeber / Förderer

EU - Europäische Union